"False teachers are leading retail investors astray," warns Hedgeye Health Policy analyst Emily Evans.
"(Mis)Leading Reddit users will not save Clover Health (CLOV) from what it is: a regional insurance company with a bad business model and a poor record of performance," she adds.
Join Emily below for a special webcast where she shines a light on Clover Health.
Among other things, she will discuss how:
- CLOV has mischaracterized opportunities to expand TAM via a new federal program
- Customer acquisition is fiercely competitive and their technology platform “Clover Assistant” is no special sauce
- Its small size provides little purchasing power for health care services: a prerequisite for success
- Customer satisfaction and patient outcomes put it at risk for regulatory intervention
CLICK HERE to access the associated slides
